Changes in insulin sensitivity are probably secondary to inflammation although molecules other than cytokines in the serum can also reduce insulin signaling including FFAs, lipotoxicity, hyperglycemia, and hyperinsulinemia. This evidence concerns the gene INS and Hyperglycemia.